Selling pressure on Avalanche (AVAX) has eased at the bottom of the chart.
Avalanche Corrects Upwards, But Struggles Below $20
Tweet on Twitter
Share on Facebook
Google+
Pinterest
Tweet on Twitter
Share on Facebook
Google+
Pinterest
